If your clinic’s website, Google Ads campaigns, or social media content hasn’t been reviewed since September 2025, there is a real chance some of it is no longer compliant with Australian advertising law.
The new AHPRA guidelines for non-surgical cosmetic procedures came into effect on 2 September 2025. They represent the most significant regulatory shift the Australian cosmetic injectables industry has seen in years, covering everything from how practitioners assess patients to how clinics are allowed to advertise online.
Most of the coverage written about these guidelines focuses on the clinical obligations, training requirements, consultation protocols, and consent processes. That information matters, but for clinic owners and practice managers, there is an equally important question that has received far less attention: what do these guidelines actually mean for how your clinic markets itself?
Below, we cover both the clinical requirements that cosmetic injectables clinic owners need to understand and the advertising and marketing implications that most coverage of these guidelines has not addressed.
Key Takeaways From This Article
The following summarises the most important compliance and advertising obligations introduced by AHPRA’s September 2025 guidelines for Australian cosmetic injectable clinics.
⬇️ Practice and Clinic Requirements
- Face-to-face or telehealth consultation required before every injectable prescription, no remote or asynchronous prescribing.
- Full psychological assessment required including screening for body dysmorphic disorder.
- Registered nurses must have a minimum of one year of full-time general clinical experience before performing cosmetic procedures.
- Mandatory seven-day cooling-off period for patients under 18.
- Clinic owners, prescribing practitioners and treating practitioners all share compliance responsibility.
⬇️ Advertising Restrictions
- Influencer testimonials, AI-generated imagery and before/after images of under 18s are banned.
- Language implying guaranteed or risk-free outcomes is prohibited, including “safe”, “painless”, “flawless”, “world renowned”, “happier you”.
- Financial inducements and promotional discounts to drive bookings are not permitted.
- Practitioner registration details must appear in all advertising.
- Higher-risk procedure ads must be classified as adult content on social media.
⬇️ TGA layer
- Cosmetic injectables are Schedule 4 prescription medicines, advertising them to the general public is prohibited.
- References to “wrinkle reducing injections” or “dermal fillers” in promotional contexts are not permitted, including through abbreviations, nicknames and hashtags.
Why the Guidelines Were Introduced
The Australian cosmetic injectables industry has grown rapidly over the past decade. With that growth came a corresponding rise in complaints, inconsistent standards, and increasing concern about how procedures were being promoted to consumers.
Between September 2022 and March 2025, AHPRA received approximately 360 notifications related to non-surgical cosmetic procedures. Its dedicated cosmetic surgery hotline received over 1,500 calls during the same period. The Therapeutic Goods Administration, which regulates advertising of prescription medicines including cosmetic injectables, submitted more than 12,000 removal requests to social media platforms in a single financial year, including over 2,500 advertisements related to cosmetic injectable products.
The AHPRA CEO described the purpose of the new guidelines simply: putting patients before profits. The reforms were designed to address inadequate training, misleading advertising, and a culture of financial incentives that regulators felt was compromising patient welfare.
What the New Guidelines Cover
AHPRA published two separate documents that came into effect on 2 September 2025:
The first is the Guidelines for registered health practitioners who perform non-surgical cosmetic procedures. The second is the Guidelines for advertising higher risk non-surgical cosmetic procedures.
Together, these guidelines apply to all registered health practitioners under Australia’s National Law who perform or advertise non-surgical cosmetic procedures. This includes registered nurses, nurse practitioners, enrolled nurses, dentists, podiatrists, and Chinese medicine practitioners. Medical practitioners are regulated under a separate framework through the Medical Board of Australia.
The new guidelines replace the Nursing and Midwifery Board of Australia’s previous Position Statement on nurses and cosmetic medical procedures, and bring non-medical practitioners in line with the standards already applied to doctors.
Core Clinical Requirements
Before getting to the marketing implications, it is worth understanding the clinical changes, particularly because several of them have direct consequences for how clinics operate and how they must represent themselves to patients.
Patient Assessments and Consultations
Every patient must receive a full consultation before any injectable treatment is prescribed. This consultation must be conducted either face to face or via telehealth and must include a review of medical history, a physical assessment, a discussion of alternative treatment options including no treatment, and an evaluation of whether the patient’s expectations are realistic.
Prescribing cannot be done remotely, asynchronously, by text, by email, or online. Batch prescribing, meaning providing a single prescription for multiple patients at once, is also prohibited. A consultation is required every time an injectable is prescribed, not just at the initial visit.
Practitioners are also required to screen for body dysmorphic disorder and other underlying psychological conditions. Where a psychological condition is identified or suspected, the patient must be referred to an independent registered health practitioner before treatment proceeds.
Informed Consent
Informed consent must be obtained using a structured process. Patients must receive clear, plain-language information both verbally and in writing before any procedure takes place. This information must include a full breakdown of all costs including maintenance, deposits, and payment terms, along with a clear statement that Medicare does not cover these procedures.
Practitioners must also disclose their own qualifications and registration details, and the qualifications of any other practitioners involved in the patient’s care.
Practitioner Experience and Training
For registered nurses, the guidelines introduce a minimum experience threshold. RNs must now have at least one year of full-time experience in a general clinical setting, such as a hospital, aged care facility, or community health service, before performing non-surgical cosmetic procedures. Enrolled nurses must work under the direct supervision of a registered nurse when performing these procedures.
All practitioners are required to engage in ongoing continuing professional development specific to cosmetic procedures.
Patients Under 18
For patients under the age of 18, a mandatory seven-day cooling-off period applies between the initial consultation and any treatment. Advertising cosmetic procedures to people under 18 is completely prohibited. Botox and dermal fillers are specifically noted as inappropriate for this age group. Practitioners must assess maturity and capacity to give informed consent, and are encouraged to involve a parent or guardian in the process.
Shared Responsibility
One of the more significant aspects of the new guidelines is the explicit shared responsibility framework. Compliance is not solely the obligation of the practitioner performing the treatment. Clinic owners, prescribing practitioners, and treating practitioners all share responsibility for ensuring procedures are performed safely and advertising meets the required standards. This means clinic operators cannot assume that responsibility sits entirely with clinical staff.
What the Guidelines Mean for Your Clinic’s Digital Marketing
This is the most critical section that most articles about the AHPRA guidelines fail to address properly. The advertising restrictions introduced in September 2025 have practical consequences for every clinic’s digital marketing, and the obligations go well beyond simply removing a few Instagram posts.
What You Can No Longer Do
The guidelines prohibit a specific and fairly extensive list of advertising practices. Understanding exactly what is banned is the starting point for any compliance review.
Influencer testimonials are banned
Any arrangement where a social media influencer, content creator, or user receives free or discounted treatment in exchange for promoting the clinic or its procedures is prohibited. This applies regardless of whether the arrangement is explicit or implied.
Liking or sharing patient comments may now constitute a testimonial endorsement
AHPRA’s position is that engaging with patient reviews or comments in ways that effectively amplify them as promotional content can breach the guidelines. Clinics should seek legal advice on their specific social media engagement practices.
Before and after images involving patients under 18 are prohibited
If your content library includes any such images, they need to be removed from all platforms immediately.
AI-generated before and after images are banned
Predictive imagery that shows how a patient might look post-treatment, whether generated by artificial intelligence or other tools, is not permitted.
Language suggesting guaranteed or risk-free outcomes is not allowed
This includes terms such as “flawless”, “perfect results”, “risk-free”, “painless”, “safe”, “world renowned”, “happier you”, and “restore self-esteem”. Copy that implies a procedure will deliver a guaranteed outcome, or that minimises the clinical nature of the treatment, is non-compliant.
Sexualised images and lifestyle-focused visuals are restricted
Content that glamorises procedures, uses beach settings or similar aspirational imagery to promote treatments, or associates injectable procedures with social or professional success needs to be reviewed carefully.
Financial inducements and promotional discounts are prohibited
Offering loans, commercial payment plans, or discounts as a mechanism to drive procedure bookings is no longer permitted. This also includes financially incentivising third parties, including influencers, to promote procedures.
What You Must Now Include
The guidelines are not only about what to remove. They also specify what must be present in advertising for it to be compliant.
Practitioner registration details must appear in all advertising materials. This means patients must be able to identify the registered health practitioner associated with the clinic and verify their qualifications through the AHPRA register. This obligation applies across your website, social media, and any paid advertising.
For higher-risk procedures, including cosmetic injectables, thread lifts, lipolysis, and platelet-rich plasma treatments, advertising must be classified as adult content on social media platforms. This is a specific technical step that most clinics have not taken.
What This Means for Your Clinic’s Google Ads
The AHPRA advertising guidelines apply to Google Ads in the same way they apply to any other public-facing communication. Ad copy that was written before September 2025 may contain language that is now non-compliant.
Specifically, any headlines or descriptions that use terms like “safe”, “painless”, “natural results guaranteed”, or any language suggesting a guaranteed or risk-free outcome need to be revised. Promotional copy that references discounts or special offers as a mechanism to drive bookings also requires review.
Beyond AHPRA, Google’s own healthcare advertising policies add a further layer of restriction. Campaigns targeting cosmetic procedures must comply with both sets of requirements simultaneously. This is one of the main reasons generic agencies consistently underperform when running Google Ads for cosmetic injectable clinics, they either do not understand the restrictions or they default to generic promotional copy that creates compliance risk.
Compliant Google Ads for cosmetic injectable clinics focus on consultation intent and patient education rather than promotional language. Copy that describes what a consultation involves, who the practitioner is, and what the clinic specialises in is both more compliant and generally more effective at attracting the right kind of patient.
What This Means for Your Clinic’s Website
Treatment pages are the most common place where banned language appears. Terms like “safe”, “natural results”, “painless procedure”, and outcome-guarantee language are standard in cosmetic clinic website copy written before these guidelines came into effect.
A systematic audit of every treatment page is necessary. This includes reviewing page titles, headings, body copy, and any testimonial-style content. Practitioner credentials and registration details should be clearly visible on treatment pages and on the about page, not just in the footer.
Before and after galleries need to be reviewed to ensure no images of patients under 18 are included, and to consider whether the framing of the gallery as a whole implies guaranteed outcomes.
What This Means for Your Clinic’s Social Media
Instagram and Facebook content requires the most thorough review. Influencer partnerships that have not been formally restructured need to be addressed. Posts that use banned language, feature before and after content in a promotional context, or imply guaranteed results need to be removed or edited.
Engagement with patient reviews is an area of genuine ambiguity. The safe approach is to respond to reviews in a neutral, professional way rather than liking or sharing content that functions as a testimonial endorsement.
Higher-risk procedure content should be reviewed against the adult content classification requirement across all platforms.
The TGA (Therapeutic Goods Administration) Layer
It is important to understand that AHPRA and the TGA operate as two separate but overlapping regulatory frameworks. AHPRA governs practitioner conduct and advertising obligations under the National Law. The TGA regulates the advertising of therapeutic goods, including prescription medicines.
Most cosmetic injectables are classified as Schedule 4 prescription-only medicines under the Therapeutic Goods Act 1989. Advertising prescription medicines to the general public is prohibited under TGA regulations.
Importantly, the TGA has clarified that it no longer permits references to terms such as “wrinkle reducing injections” or “dermal fillers” in content where a reasonable consumer would understand the intention is to promote a prescription medicine. This includes references made through acronyms, nicknames, abbreviations, and hashtags.
In practice, this creates a significant challenge for clinics trying to describe their services online. The TGA’s position means that even indirect references to specific injectable products or their generic equivalents may be non-compliant in certain contexts. Clinics should seek specific advice about how they describe their treatment offerings on their website and in their advertising.
Consequences of Non-Compliance
AHPRA has been explicit about its intent to enforce these guidelines. The consequences for non-compliance range from formal warnings and conditions placed on a practitioner’s registration through to business closure in serious cases.
The TGA has already demonstrated its willingness to act. In the financial year preceding the new guidelines, it submitted more than 12,000 removal requests to social media platforms and sent approximately 100 targeted guidance letters directly to providers in the cosmetic injectables space.
Non-compliance is not a theoretical risk. It is an active area of regulatory scrutiny, and the enforcement infrastructure is already operational.
A Compliance Checklist for Cosmetic Injectables Clinic Owners
If you have not already conducted a full compliance review since September 2025, the following areas should be your starting point.
- Review all website copy for banned terms including “safe”, “painless”, “guaranteed”, “flawless”, “world renowned”, and any language that implies risk-free outcomes or guaranteed results.
- Audit your Google Ads headlines and descriptions for the same language, and review any promotional copy that references discounts or financial incentives.
- Check all social media content for influencer posts, before and after images involving patients under 18, AI-generated imagery, and any content that has been liked or shared in a way that functions as a testimonial endorsement.
- Classify higher-risk procedure content as adult content on all relevant platforms.
- Ensure practitioner registration details are clearly visible in all advertising including your website, social media profiles, and any paid advertising.
- Verify that all nursing staff meet the minimum one year of full-time general clinical experience requirement before performing procedures.
- Confirm that consultation and prescribing protocols comply with the face-to-face or “telehealth” requirement, and that no remote or asynchronous prescribing is occurring.
- Document the cooling-off period process for any patients under 18.
Compliant Digital Marketing for Australian Cosmetic Injectable Clinics
The combined effect of the AHPRA advertising guidelines and TGA restrictions makes compliant marketing genuinely difficult for cosmetic injectable clinics. The language that drives engagement in other industries, outcome-focused copy, promotional offers, social proof through testimonials, is largely off the table.
What remains is marketing built around clarity, credibility, and consultation intent. Clinics that communicate their practitioner qualifications clearly, describe their processes honestly, and focus on attracting patients who are genuinely informed and ready to consult tend to produce better enquiry quality and better patient relationships than those relying on promotional tactics.
At Vstock Media, we work exclusively with Australian cosmetic injectable clinics. Every Google Ads campaign, landing page, and piece of website content we produce is built with the AHPRA and TGA advertising requirements in mind. We understand what compliant marketing looks like in this space because it is the only space we work in.
If you would like a review of your clinic’s current marketing compliance or want to understand how to build visibility in search without creating regulatory risk, we are happy to have that conversation.
Frequently Asked Questions About AHPRA Guidelines for Cosmetic Injectable Clinics
Do the AHPRA guidelines apply to clinic owners who are not practitioners?
Yes. The shared responsibility framework makes clear that clinic owners share compliance obligations alongside the prescribing and treating practitioners. Owners cannot assume responsibility sits entirely with clinical staff.
When did the new AHPRA cosmetic guidelines come into effect?
The guidelines came into effect on 2 September 2025. They were first published in advance on 3 June 2025 to give practitioners and clinic operators time to prepare.
Can cosmetic injectable clinics use before and after photos in advertising?
Before and after images of patients under 18 are completely prohibited. For adult patients, before and after imagery used in advertising must not imply guaranteed outcomes, must not be digitally enhanced or airbrushed in ways that mislead, and must not be AI-generated. Clinics should review their existing image libraries carefully against these requirements.
Are Google Ads affected by the AHPRA advertising guidelines?
Yes. The guidelines apply to all public-facing advertising, including Google Ads. Headlines and descriptions that use terms like “safe”, “painless”, “guaranteed results”, or promotional discount language need to be reviewed and revised for compliance.
What terms are banned in cosmetic injectable advertising?
The guidelines prohibit language that implies guaranteed or risk-free outcomes. Specific terms that are non-compliant include “safe”, “painless”, “flawless”, “perfect results”, “world renowned”, “happier you”, and “restore self-esteem”. Copy that minimises the clinical nature of a procedure or overstates likely results is also non-compliant.
What is the TGA’s role in cosmetic injectable advertising?
The TGA operates separately from AHPRA and regulates the advertising of therapeutic goods, including prescription medicines. Most cosmetic injectables are Schedule 4 prescription-only medicines and cannot be advertised to the general public. The TGA no longer permits references to “wrinkle reducing injections” or “dermal fillers” in promotional contexts, including through abbreviations, nicknames and hashtags.
What are the consequences of non-compliance with the AHPRA guidelines?
Consequences range from formal warnings and conditions placed on a practitioner’s registration through to business closure in serious cases. The TGA has already sent approximately 100 targeted guidance letters to providers and submitted more than 12,000 social media removal requests. Non-compliance is an active area of enforcement, not a theoretical risk.
Request a Strategy Session
If you run an established cosmetic injectable clinic and want clearer, more predictable patient enquiries, let's have a focused conversation.